Vanguard Group Inc Edgewise Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,466,849 shares of EWTX stock, worth $121 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,466,849

Previous 4,516,063 1.09%

Holding current value

$121 Million

Previous $121 Million 1.05%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$26.63 - $36.62 $1.31 Million - $1.8 Million	-49,214 Reduced 1.09%	4,466,849 $119 Million
Q3 2024 Nov 13, 2024	BUY	$15.88 - $29.5 $125,404 - $232,961	7,897 Added 0.18%	4,516,063 $121 Million
Q2 2024 Aug 13, 2024	BUY	$15.08 - $21.23 $7.4 Million - $10.4 Million	490,733 Added 12.22%	4,508,166 $81.2 Million
Q1 2024 May 10, 2024	BUY	$9.25 - $19.97 $17.5 Million - $37.8 Million	1,892,053 Added 89.02%	4,017,433 $73.3 Million
Q4 2023 Feb 14, 2024	BUY	$5.51 - $12.1 $335,884 - $737,603	60,959 Added 2.95%	2,125,380 $23.3 Million
Q3 2023 Nov 14, 2023	BUY	$5.73 - $7.69 $186,007 - $249,632	32,462 Added 1.6%	2,064,421 $11.8 Million
Q2 2023 Aug 14, 2023	BUY	$5.71 - $10.29 $149,225 - $268,918	26,134 Added 1.3%	2,031,959 $15.7 Million
Q1 2023 May 15, 2023	BUY	$6.66 - $11.33 $151,987 - $258,561	22,821 Added 1.15%	2,005,825 $13.4 Million
Q4 2022 Feb 10, 2023	BUY	$7.58 - $11.08 $1.75 Million - $2.56 Million	231,159 Added 13.2%	1,983,004 $17.7 Million
Q3 2022 Nov 14, 2022	BUY	$8.08 - $13.58 $4.24 Million - $7.13 Million	525,277 Added 42.82%	1,751,845 $17.2 Million
Q2 2022 Aug 12, 2022	BUY	$5.67 - $9.87 $87,743 - $152,738	15,475 Added 1.28%	1,226,568 $9.76 Million
Q1 2022 May 13, 2022	BUY	$9.1 - $18.97 $106,406 - $221,816	11,693 Added 0.97%	1,211,093 $11.7 Million
Q4 2021 Feb 14, 2022	BUY	$14.41 - $22.41 $8.82 Million - $13.7 Million	611,879 Added 104.15%	1,199,400 $18.3 Million
Q3 2021 Nov 12, 2021	BUY	$14.11 - $24.1 $65,724 - $112,257	4,658 Added 0.8%	587,521 $9.75 Million
Q2 2021 Aug 13, 2021	BUY	$21.33 - $30.25 $12.4 Million - $17.6 Million	582,863 New	582,863 $12.4 Million

Others Institutions Holding EWTX

# of Institutions

215

Shares Held

98.3M

Call Options Held

885K

Put Options Held

232K

View Full List

About Edgewise Therapeutics, Inc.

Ticker EWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,171,700
Market Cap $1.71B
Description
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...

More about EWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Edgewise Therapeutics, Inc. Transaction History